Duality Advisers’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-13,982
Closed -$976K 603
2023
Q3
$976K Sell
13,982
-55,876
-80% -$3.96M 0.12% 293
2023
Q2
$4.83M Sell
69,858
-686
-1% -$48.8K 0.61% 6
2023
Q1
$5.24M Buy
70,544
+13,442
+24% +$1.13M 0.59% 17
2022
Q4
$5.32M Buy
+57,102
New +$5.51M 0.61% 5
2022
Q2
Sell
-56,436
Closed -$5.71M 647
2022
Q1
$5.71M Buy
+56,436
New +$5.93M 0.61% 5
2021
Q3
Sell
-2,886
Closed -$241K 569
2021
Q2
$241K Buy
+2,886
New +$236K 0.02% 495
2021
Q1
Sell
-70,593
Closed -$4.82M 557
2020
Q4
$4.82M Buy
+70,593
New +$4.59M 0.36% 53
2020
Q3
Sell
-16,570
Closed -$1.08M 589
2020
Q2
$1.08M Buy
+16,570
New +$1.04M 0.1% 242
2020
Q1
Sell
-78,778
Closed -$5.85M 76
2019
Q4
$5.85M Sell
78,778
-312,352
-80% -$21.9M 0.35% 103
2019
Q3
$24.7M Buy
391,130
+219,910
+128% +$13M 1.38% 5
2019
Q2
$9.33M Buy
171,220
+86,930
+103% +$4.68M 0.82% 27
2019
Q1
$4.55M Buy
84,290
+25,060
+42% +$1.55M 0.27% 113
2018
Q4
$3.88M Buy
+59,230
New +$4.42M 0.23% 111

Other funds holding CVS

Duality Advisers's CVS Position: Q4 2023 in Review

Duality Advisers sold out of CVS Health (CVS) in Q4 2023, closing a stake of 13,982 shares — an estimated $976K sold.

Duality Advisers first reported a position in CVS in Q4 2018 and held it in 13 quarters. The position peaked at $24.7M in Q3 2019. 2,257 funds tracked by Wall St. Rank hold CVS as of Q4 2023.

  • Duality Advisers reported no remaining CVS Health position as of Q4 2023 after selling out during the quarter.
  • Duality Advisers sold 13,982 CVS Health shares in Q4 2023, an estimated $976K.
  • Duality Advisers first reported a position in CVS Health in Q4 2018 and held it in 13 quarters.
  • Duality Advisers's CVS Health position peaked at $24.7M in Q3 2019.
  • 2,257 funds tracked by Wall St. Rank held CVS Health as of Q4 2023.

Based on Duality Advisers's 13F filing for Q4 2023, filed 1 Feb 2024.